Q1 2021 Holdings
Filed 2021-05-17 | 53 holdings | $321.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $232.8M | 3,156,981 | 72.5% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $23.9M | 800,000 | 7.4% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $17.2M | 413,458 | 5.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $16.3M | 700,000 | 5.1% |
| Unum Therapeutics Inc(COGT) | COM | 19240Q201 | $12.5M | 1,420,500 | 3.9% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $9.2M | 250,000 | 2.9% |
| Annexon Inc(ANNX) | COM | 03589W102 | $4.4M | 159,622 | 1.4% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $4.2M | 112,928 | 1.3% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $124.2K | 3,743,875 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $81.7K | 2,732,501 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $49.8K | 3,204,392 | 0.0% |
| Instil BIO Inc | COM | 45783C101 | $46.3K | 1,846,850 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $41.5K | 1,260,877 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $39.5K | 1,410,000 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $34.3K | 1,056,812 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $29.1K | 934,602 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $27.6K | 900,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $24.0K | 200,000 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $18.6K | 1,010,812 | 0.0% |
| Bioxcel Therapeutics Inc(BTAIEUR) | COM | 09075P105 | $17.3K | 400,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $13.2K | 140,000 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $11.9K | 419,853 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $10.8K | 476,547 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $10.1K | 260,920 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $9.3K | 480,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $9.2K | 550,000 | 0.0% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $7.7K | 2,300,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $7.4K | 1,200,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $7.4K | 400,000 | 0.0% |
| Landos Biopharma Inc | COM | 515069102 | $7.1K | 734,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $6.6K | 200,000 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $6.3K | 300,000 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $5.5K | 125,000 | 0.0% |
| Therapeutics Acquisition COR | COM CL A | 88339T103 | $5.3K | 500,000 | 0.0% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $4.9K | 150,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $4.8K | 800,000 | 0.0% |
| Viracta Therapeutics Inc | COM | 92765F108 | $4.3K | 470,000 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $3.4K | 230,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $3.4K | 300,000 | 0.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $3.3K | 100,000 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $3.1K | 300,000 | 0.0% |
| Lucira Health Inc | COM | 54948U105 | $3.0K | 250,000 | 0.0% |
| FS Development Corp II | COM CL A | 30318F100 | $3.0K | 300,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $2.8K | 62,000 | 0.0% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $2.8K | 150,000 | 0.0% |
| Eargo Inc | COM | 270087109 | $2.5K | 50,000 | 0.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $2.4K | 224,071 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $2.2K | 200,000 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $2.2K | 125,010 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $2.1K | 200,000 | 0.0% |